OBJECTIVE: The purpose of this study was to analyze our experience with saline-linked cautery in hepatic surgery. SUMMARY BACKGROUND DATA: Safe and efficient hepatic parenchymal transection is predicated on the ability to simultaneously address 2 tasks: parenchymal dissection and hemostasis. To date, no single instrument has been designed that addresses both of these tasks. Saline-linked cautery is now widely used in liver surgery and is reported to decrease blood loss during liver transection, but data on its exact benefits are lacking. METHODS: From a single institution, prospective liver surgery database, we identified 32 consecutive patients with noncirrhotic livers who underwent resection for primary or metastatic disease using a 2-surgeon technique with saline-linked cautery and ultrasonic dissection (SLC+UD) from December 2002 to January 2004. From the same database, we identified a contemporary and matched set of 32 patients who underwent liver resection with similar indications using ultrasonic dissection alone (UD alone). Operative and anesthetic variables were retrospectively analyzed to identify differences between the 2 groups. RESULTS: The 2 groups were equivalent in terms of age, gender, tumor histology, tumor number, and tumor size. The UD+SLC group had a decreased duration of inflow occlusion (20 minutes versus 30 minutes, P = 0.01), blood loss (150 mL versus 250 mL, P = 0.034), and operative time (187 minutes versus 211 minutes, P = 0.027). Postoperative liver function and complication rates were similar in each group. CONCLUSIONS: The 2-surgeon technique for liver parenchymal transection using SLC and UD in noncirrhotic livers is safe and may provide advantages over other techniques.
OBJECTIVE: The purpose of this study was to analyze our experience with saline-linked cautery in hepatic surgery. SUMMARY BACKGROUND DATA: Safe and efficient hepatic parenchymal transection is predicated on the ability to simultaneously address 2 tasks: parenchymal dissection and hemostasis. To date, no single instrument has been designed that addresses both of these tasks. Saline-linked cautery is now widely used in liver surgery and is reported to decrease blood loss during liver transection, but data on its exact benefits are lacking. METHODS: From a single institution, prospective liver surgery database, we identified 32 consecutive patients with noncirrhotic livers who underwent resection for primary or metastatic disease using a 2-surgeon technique with saline-linked cautery and ultrasonic dissection (SLC+UD) from December 2002 to January 2004. From the same database, we identified a contemporary and matched set of 32 patients who underwent liver resection with similar indications using ultrasonic dissection alone (UD alone). Operative and anesthetic variables were retrospectively analyzed to identify differences between the 2 groups. RESULTS: The 2 groups were equivalent in terms of age, gender, tumor histology, tumor number, and tumor size. The UD+SLC group had a decreased duration of inflow occlusion (20 minutes versus 30 minutes, P = 0.01), blood loss (150 mL versus 250 mL, P = 0.034), and operative time (187 minutes versus 211 minutes, P = 0.027). Postoperative liver function and complication rates were similar in each group. CONCLUSIONS: The 2-surgeon technique for liver parenchymal transection using SLC and UD in noncirrhotic livers is safe and may provide advantages over other techniques.
Authors: Y Yamamoto; I Ikai; M Kume; Y Sakai; A Yamauchi; H Shinohara; T Morimoto; Y Shimahara; M Yamamoto; Y Yamaoka Journal: World J Surg Date: 1999-10 Impact factor: 3.352
Authors: Jean-Christophe Weber; Giuseppe Navarra; Long R Jiao; Joanna P Nicholls; Steen Lindkaer Jensen; Nagy A Habib Journal: Ann Surg Date: 2002-11 Impact factor: 12.969
Authors: Andreas Andreou; Luca Viganò; Giuseppe Zimmitti; Daniel Seehofer; Martin Dreyer; Andreas Pascher; Marcus Bahra; Wenzel Schoening; Volker Schmitz; Peter C Thuss-Patience; Timm Denecke; Gero Puhl; Jean-Nicolas Vauthey; Peter Neuhaus; Lorenzo Capussotti; Johann Pratschke; Sven-Christian Schmidt Journal: J Gastrointest Surg Date: 2014-08-27 Impact factor: 3.452
Authors: Ching-Wei D Tzeng; Amanda B Cooper; Jean-Nicolas Vauthey; Steven A Curley; Thomas A Aloia Journal: HPB (Oxford) Date: 2013-08-26 Impact factor: 3.647
Authors: Kristoffer W Brudvik; Sameer H Patel; Christina L Roland; Claudius Conrad; Keila E Torres; Kelly K Hunt; Janice N Cormier; Barry W Feig; Thomas A Aloia; Jean-Nicolas Vauthey Journal: J Gastrointest Surg Date: 2015-05-22 Impact factor: 3.452
Authors: Andreas Andreou; Thomas A Aloia; Antoine Brouquet; Paxton V Dickson; Giuseppe Zimmitti; Dipen M Maru; Scott Kopetz; Evelyne M Loyer; Steven A Curley; Eddie K Abdalla; Jean-Nicolas Vauthey Journal: Ann Surg Date: 2013-06 Impact factor: 12.969